True Health Diagnostics: The Referrals Behind the Investment Returns

The True Health Diagnostics lawsuit led to a $4.25 million civil settlement with the laboratory’s former chief executive over alleged kickbacks for test referrals. The Justice Department alleged that hospitals billed for laboratory tests and money returned to the doctors ordering them. An insider who saw the orders, sales commissions or physician payments may recognize how those pieces fit together.

True Health was a clinical laboratory in Frisco, Texas. A whistleblower brought the False Claims Act case, and the United States joined it. In its April 2022 account of the complaint, the Justice Department alleged that True Health, Boston Heart Diagnostics and small Texas hospitals participated in a referral arrangement that rewarded doctors for sending laboratory business their way.

The alleged scheme involved hospital executives, recruiters, sales employees and referring physicians. In the government’s account, the doctor’s order created business for the laboratory, the hospital’s bill brought in revenue, and part of that money made its way back to the doctor.

Do Doctors Get Kickbacks for Ordering Tests?

The government alleged that doctors received kickbacks for ordering tests through management service organizations. Recruiters allegedly set up these companies, called MSOs, to distribute payments that looked like investment returns but depended on the doctors’ laboratory referrals.

The money started with the hospitals. According to the government’s complaint, the hospitals paid part of their laboratory profits to recruiters, who passed funds to referring physicians. True Health and Boston Heart executives and sales staff allegedly used those payments to increase referrals and their own bonuses and commissions.

That is what the investment label concealed, according to the government: a payment offered in exchange for an order.

True Health’s alleged inducements also included processing and handling fees paid to blood-draw companies and waivers of patient copayments and deductibles. According to the complaint, a top-referring doctor received monthly consulting fees for advising a board True Health did not have.

Hospital Billing Raised the Value of the Test

Little River Healthcare allegedly billed laboratory tests as hospital outpatient services to obtain higher reimbursement. True Health and Boston Heart performed the testing described in the civil complaint, while the hospital billing arrangement increased what could be charged for it.

In the separate criminal case against former True Health sales executives, the indictment charged that physicians and marketers received incentives to direct testing to rural hospitals and the laboratory. The Justice Department’s April 2025 account of that criminal case describes Little River Healthcare and Stamford Memorial Hospital as rural Texas hospitals that partnered with True Health, which specialized in advanced cardiovascular lipid testing.

According to that criminal-case account, True Health processed the blood tests for a fee. The hospitals billed insurers for hospital outpatient services at much higher rates than True Health could receive as a clinical laboratory, then paid part of their laboratory revenue to marketers. The marketers passed a portion to referring physicians through MSOs.

A laboratory employee could see the testing without seeing the hospital’s claim. A hospital billing employee could see the claim without seeing the physician’s MSO payment.

The Clinical Reason Belongs With the Order

The civil complaint alleged that many tests generated by the referral scheme were not reasonable and necessary. It identified Medicare, Medicaid and TRICARE as programs billed for testing induced by True Health’s alleged kickbacks. Patients underwent testing the government alleged they did not need, and taxpayers paid the bill.

Under Medicare’s rules for diagnostic tests, a reviewer may need the clinical record from the ordering practitioner even though the laboratory is seeking payment. The requisition and the medical chart answer different parts of the same question: what was ordered, and why this patient needed it.

That separation has been a laboratory compliance issue for decades. Model Plan Helps Laboratories Fight Fraud, published in Laboratory Medicine in 1997, described recommendations for uniform requisition forms with space for a diagnosis code documenting the medical necessity of each test. It also described notices explaining the individual tests within a laboratory profile and how the laboratory would bill for them. Those recommendations connect the order to the actual tests and their charges, which is precisely where a referral-driven testing arrangement needs scrutiny.

Little River’s Medical Director Fees

Little River’s former chief executive agreed to a civil payment of $5,343,630 in October 2024. The Justice Department said he did not contest the allegations and accepted responsibility for them.

The allegations he accepted described the payment arrangement: after a physician told Little River about his potential laboratory referral volume, the hospital chief executive agreed to pay him $2,000 per month, from February 2015 through May 2017, in kickbacks disguised as medical director fees. The discussion began with the testing business the doctor could send. The medical director title supplied the description for the monthly payment.

The hospital executive also faced a separate criminal case over health care kickbacks. In its November 2023 account of the jury verdict, the Justice Department reported that he was among the defendants convicted of conspiring to violate the Anti-Kickback Statute.

Separate Settlements for Physicians, Marketers and Executives

The True Health case produced separate civil resolutions involving people who ordered tests, people who recruited that business and people who ran the companies.

On June 28, 2022, the government announced that fifteen Texas physicians had agreed to pay a total of $2,831,280. The allegations concerned violations of the Anti-Kickback Statute and Stark Law through payments from nine MSOs for referrals involving Little River, True Health or Boston Heart. Little River allegedly funded payments to some doctors through volume-based commissions to independent recruiters, who then paid physicians through the MSOs.

The September 8, 2025 resolutions reached True Health’s former chief executive, two physicians and seven marketers. The former laboratory executive’s settlement covered alleged false claims to Medicare, Medicaid and TRICARE from January 2015 through May 2018. The Justice Department alleged that he received the warning that the marketers “are a powder keg waiting to explode on us” and still kept True Health involved. The settlement also covered alleged consulting fees, processing and handling fees, and patient-payment waivers.

The two physicians and seven marketers agreed to an additional $1,818,462. The marketers included True Health’s former account executive and director of strategic accounts, Boston Heart sales personnel, and outside marketing-company owners.

By that announcement, the Justice Department reported over $59 million in civil False Claims Act settlements for MSO kickbacks, including recoveries from 50 physicians. That was the wider enforcement effort, reaching beyond True Health’s former executive.

A Different Company Between the Lab and the Doctor

A separate whistleblower complaint against Boston Heart shows how an intermediary could be part of the sales pitch itself. The complaint quoted a company representative explaining third-party payments:

The same complaint alleged that a representative arranged packaging-fee payments to a physician’s spouse through third parties. That is a separate allegation against Boston Heart, but it illuminates the recurring practice: putting another company between the laboratory and the person benefiting from the referral. In the True Health case, the government alleged that hospital profits passed through recruiters and MSOs to doctors. The extra business in the middle was part of the alleged payment route.

What Evidence Is Needed to Prove Fraud?

In a healthcare fraud case involving laboratory referrals, we work with insiders to connect the order, the claim and the payment to the doctor. The clinical reason for the test and the decisions behind the payment matter together.

In the True Health allegations, the distribution formula connected the physician’s money to referrals, and the hospital arrangement connected the test to higher reimbursement. The government’s account of warnings to the former laboratory chief executive adds another part of the case: what management knew while the arrangement continued. We examine those connections with you, from the clinical order through the payment and the people who authorized it.

An account executive may recognize the compensation arrangement. Someone in a physician practice may know why a particular laboratory received the orders. A hospital finance employee may understand the difference between what the hospital paid the laboratory and what it billed insurers. That working knowledge gives meaning to documents that otherwise describe only one part of the business.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Saw How the Referral Was Paid

If your work connected laboratory orders, hospital claims or payments to physicians, speak to one of our whistleblower experts about how the referrals were paid. We work with you to build your strongest case around that knowledge and bring in laboratory fraud whistleblower lawyers who understand referral payments and hospital billing. We stay beside you as your account of the business becomes a case for recovering public money.